Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

Overview of attention for article published in New England Journal of Medicine, August 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 3 Google+ posts from 3 users.

[...] A central clinical events adjudication committee, whose members were unaware of the trial-group... [...] A central…

#Belviq is the first drug that has been shown to help people lose weight and keep it off for several... #Belviq is the first…

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients Cardiovascular Safety of Lorcaserin in Overweight or Obese…

This page shows the most recent Google+ posts that mention this research output.

Click here to find out how to access more activity.